Miles Wang Leaves OpenAI for AI Drug Discovery | Tech News

Miles Wang, OpenAI’s young AI researcher who dropped out of Harvard, is leaving ChatGPT to launch his own startup focused on accelerating drug discovery using AI. He’s reportedly bringing other OpenAI talent with him, aiming to repurpose existing FDA-approved drugs — a faster, safer path to breakthroughs. His move mirrors a booming AI-driven healthcare trend: Chai Discovery just raised $400M at a $3.8B valuation, and Isomorphic Labs snagged $2.1B. With investors pouring billions into AI for medicine, Wang’s venture could reshape how drugs are discovered — and fast. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/06f6d22989a125be